Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions

View Full Size 

Download

• Full Size JPEG, 2940x1545, 412.7 KB
• Small JPEG, 480x252, 58.5 KB
• Preview JPEG, 144x76, 36.6 KB
• Thumbnail JPEG, 120x63, 35.1 KB